Market Positioning USD is a global leader in rapid point-of-care testing with a full portfolio including drug and alcohol, infectious disease, and women’s health tests, suggesting opportunities to upsell complementary test panels and expand into new care settings.

SME Focus Small to mid-size enterprise footprint (11-50 employees) indicates a need for scalable, cost-efficient solutions, turnkey kits, and robust training with simplified procurement to win larger contracts as they scale.

Digital Footprint Current tech stack and online presence imply potential for digital engagement, e-commerce, and support tools; leverage analytics, online demos, and self-service resources to drive direct sales and reduce sales cycles.

Competitive Benchmarking Comparable firms in the diagnostics space have multi-hundred to multi-thousand employee bases and higher revenues, suggesting USD can compete on speed, pricing, service support, and modular test offerings to attract larger clients away from incumbents.

Cross-Sell Opportunities Portfolio breadth across infectious disease, drug testing, and women's health provides a pathway to bundle offerings for healthcare facilities, labs, and corporate clients, enabling cross-sell of integrated rapid testing programs.